RWS
NBIX icon

Retirement Wealth Solutions’s Neurocrine Biosciences NBIX Stock Holding History

Retirement Wealth Solutions’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.73K Hold
34
– – ﹤0.01% 317
2026
Q1 		$4.48K Buy
34
+6
+21% +$796 ﹤0.01% 340
2025
Q4 		$3.97K Buy
28
+9
+47% +$1.3K ﹤0.01% 347
2025
Q3 		$2.67K Buy
+19
New +$2.57K ﹤0.01% 395

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Retirement Wealth Solutions's NBIX Position: Q2 2026 in Review

Retirement Wealth Solutions held its Neurocrine Biosciences (NBIX) position steady in Q2 2026 at 34 shares worth $5.73K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Retirement Wealth Solutions first reported a position in NBIX in Q3 2025 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Retirement Wealth Solutions held 34 shares of Neurocrine Biosciences worth $5.73K as of Q2 2026.
  • Retirement Wealth Solutions left its Neurocrine Biosciences share count unchanged in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #317 holding.
  • Retirement Wealth Solutions first reported a position in Neurocrine Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.